BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25225171)

  • 1. Improved overall survival and mortality in head and neck cancer with adjuvant concurrent chemoradiotherapy in national databases.
    Lin SS; Massa ST; Varvares MA
    Head Neck; 2016 Feb; 38(2):208-15. PubMed ID: 25225171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative chemoradiotherapy in patients with head and neck cancer aged 70 or older with positive margins or extranodal extension and the influence of nodal classification.
    Yoshida EJ; Luu M; David JM; Kim S; Mita A; Scher K; Shiao SL; Tighiouart M; Ho AS; Zumsteg ZS
    Head Neck; 2018 Jun; 40(6):1228-1236. PubMed ID: 29417700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of adjuvant chemoradiotherapy in T4N0 stage IV head and neck cancer: A National Cancer Database analysis.
    Kirke DN; Qureshi MM; Kamran SC; Ezzat W; Jalisi S; Salama A; Everett PC; Truong MT
    Head Neck; 2018 Jun; 40(6):1174-1184. PubMed ID: 29417687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: a systematic review with meta-analysis.
    Winquist E; Oliver T; Gilbert R
    Head Neck; 2007 Jan; 29(1):38-46. PubMed ID: 17103410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of care and outcomes of adjuvant therapy for high-risk head and neck cancer after surgery.
    Osborn VW; Givi B; Rineer J; Roden D; Sheth N; Lederman A; Katsoulakis E; Hu K; Schreiber D
    Head Neck; 2018 Jun; 40(6):1254-1262. PubMed ID: 29451961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
    Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
    Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of adjuvant therapy in the management of head and neck merkel cell carcinoma: an analysis of 4815 patients.
    Chen MM; Roman SA; Sosa JA; Judson BL
    JAMA Otolaryngol Head Neck Surg; 2015 Feb; 141(2):137-41. PubMed ID: 25474617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative concurrent chemoradiotherapy with mitomycin in advanced squamous cell carcinoma of the head and neck: results from three prospective randomized trials.
    Rewari AN; Haffty BG; Wilson LD; Son YH; Joe JK; Ross DA; Papac RJ; Sasaki CT; Fischer JJ
    Cancer J; 2006; 12(2):123-9. PubMed ID: 16630403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemoradiotherapy versus with radiotherapy alone for locally advanced salivary gland carcinoma among older patients.
    Tanvetyanon T; Fisher K; Caudell J; Otto K; Padhya T; Trotti A
    Head Neck; 2016 Jun; 38(6):863-70. PubMed ID: 26340707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparison of the NCDB and SEER Database for Research Involving Head and Neck Cancer.
    Janz TA; Graboyes EM; Nguyen SA; Ellis MA; Neskey DM; Harruff EE; Lentsch EJ
    Otolaryngol Head Neck Surg; 2019 Feb; 160(2):284-294. PubMed ID: 30129822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II feasibility trial of adjuvant chemoradiotherapy with 3-weekly cisplatin for Japanese patients with post-operative high-risk squamous cell carcinoma of the head and neck.
    Kiyota N; Tahara M; Okano S; Kawashima M; Matsuura K; Onozawa Y; Nibu K; Hayashi R; Yoshimura K; Ohtsu A
    Jpn J Clin Oncol; 2012 Oct; 42(10):927-33. PubMed ID: 22923484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conventional radiotherapy versus concurrent chemoradiotherapy versus accelerated radiotherapy in locoregionally advanced carcinoma of head and neck: Results of a prospective randomized trial.
    Ghosh-Laskar S; Kalyani N; Gupta T; Budrukkar A; Murthy V; Sengar M; Chaukar D; Pai P; Chaturvedi P; D'Cruz A; Agarwal J
    Head Neck; 2016 Feb; 38(2):202-7. PubMed ID: 25224814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node ratio influence on risk of head and neck cancer locoregional recurrence after initial surgical resection: implications for adjuvant therapy.
    Prabhu RS; Hanasoge S; Magliocca KR; Hall WA; Chen SA; Higgins KA; Saba NF; El-Deiry M; Grist W; Wadsworth JT; Chen AY; Beitler JJ
    Head Neck; 2015 Jun; 37(6):777-82. PubMed ID: 24596123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer.
    Xu B; Boero IJ; Hwang L; Le QT; Moiseenko V; Sanghvi PR; Cohen EE; Mell LK; Murphy JD
    Cancer; 2015 Apr; 121(8):1303-11. PubMed ID: 25537836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of chemoradiation for head and neck cancer in an older patient population.
    VanderWalde NA; Meyer AM; Deal AM; Layton JB; Liu H; Carpenter WR; Weissler MC; Hayes DN; Fleming ME; Chera BS
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):30-7. PubMed ID: 24725687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage.
    Kao J; Lavaf A; Teng MS; Huang D; Genden EM
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):362-70. PubMed ID: 18164833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant chemoradiotherapy versus altered fractionation radiotherapy in the radiotherapeutic management of locoregionally advanced head and neck squamous cell carcinoma: An adjusted indirect comparison meta-analysis.
    Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
    Head Neck; 2015 May; 37(5):670-6. PubMed ID: 24596112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of induction chemotherapy on survival in locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: Single center experience.
    Ock CY; Keam B; Lim Y; Kim TM; Lee SH; Kwon SK; Hah JH; Kwon TK; Kim DW; Wu HG; Sung MW; Heo DS
    Head Neck; 2016 Feb; 38(2):277-84. PubMed ID: 26104823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management of locally advanced head and neck cancer: the combination of chemotherapy with locoregional treatments.
    Bar-Ad V; Palmer J; Yang H; Cognetti D; Curry J; Luginbuhl A; Tuluc M; Campling B; Axelrod R
    Semin Oncol; 2014 Dec; 41(6):798-806. PubMed ID: 25499638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction chemotherapy before chemoradiotherapy in locally advanced head and neck cancer: the future?
    Paccagnella A; Mastromauro C; D'Amanzo P; Ghi MG
    Oncologist; 2010; 15 Suppl 3():8-12. PubMed ID: 21036883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.